![](https://endpts.com/wp-content/uploads/2019/07/David-Eveleth-Trefoil-tile-and-social.jpg)
David Eveleth, Trefoil
San Diego ophthalmic biotech upstart raises $28M on alternative to corneal transplant
Texas VC Bios Partners has found a new early-stage play to love out of San Diego, leading a $28 million Series A to help Trefoil …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.